Results 241 to 250 of about 2,930,894 (275)
Some of the next articles are maybe not open access.

Economic Assessment of Different Modalities of Immunoglobulin Replacement Therapy

Immunology and Allergy Clinics of North America, 2008
The delivery (intravenous or subcutaneous), location (home or hospital), and other factors of immunoglobulin replacement therapy are examined for cost effectiveness. Cost-minimization studies from several countries are reviewed and analyzed. A Canadian cost-minimization study is performed.
Stephen K, Membe   +5 more
openaire   +2 more sources

Intravenous and subcutaneous immunoglobulin G replacement therapy

Allergy and Asthma Proceedings, 2016
Human polyclonal immunoglobulin G (IgG) for therapeutic use has been available for decades. This drug was developed for treatment of antibody deficiency (replacement therapy), although its use has expanded into many anti-inflammatory and immunomodulatory applications in recent years. This review focuses on IgG prescribing for replacement therapy.
openaire   +2 more sources

[Replacement therapy with immunoglobulins in neonatology].

Presse medicale (Paris, France : 1983), 1984
Eighty-two neonates suffering from widespread infection detected at an early stage were treated either with antibiotics alone or with antibiotics combined with immunoglobulins administered intravenously. In 35 children, haemocultures demonstrated septicaemia due to E. coli, Klebsiella spp., staphylococci or anaerobes. Following a 6 days' treatment with
G, de Muralt, D, Sidiropoulos
openaire   +1 more source

Discontinuation of immunoglobulin replacement therapy in patients with secondary antibody deficiency

Expert Review of Clinical Immunology, 2020
Secondary immunodeficiency is becoming a greater medical concern as the usage of immunosuppressive and biological treatments has increased. Individuals with certain medical conditions, such as hematological malignancies, can also have secondary immunodeficiency.
Vishesh Patel, Juthaporn Cowan
openaire   +2 more sources

Immunoglobulin Replacement Therapy: A Twenty-Year Review and Current Update

International Archives of Allergy and Immunology, 2014
<b><i>Objective:</i></b> The expansion of immunoglobulin replacement to multiple disease entities marks a decade-long advancement in immune therapy. Parallel to its extension, the characteristics and composition of immunoglobulin products have diversified. The aim of this study was to summarize a 20-year comprehensive literature
Monika, Saeedian, Inderpal, Randhawa
openaire   +2 more sources

Immunoglobulin Replacement Therapy

2021
Abeer Feteih   +3 more
openaire   +1 more source

Outcome of immunoglobulin replacement therapy in children with rhinosinusitis

International Forum of Allergy & Rhinology, 2021
John Behnke   +4 more
openaire   +2 more sources

Immunoglobulin Replacement Therapy

2022
Marco Antonio Yamazaki-Nakashimada   +1 more
openaire   +1 more source

High cost of immunoglobulin replacement therapy

Annals of Allergy, Asthma & Immunology, 2022
Di Sun, Neil Romberg
openaire   +1 more source

Immunoglobulin Replacement Therapy: Past, Present, Future

2015
The discovery that antibody activity resides in the gammaglobulin fraction of human plasma and the development of a large-scale technique of separating serum proteins into six fractions, with one (fraction II) containing gammaglobulin, paved the way for the generation of safe and effective immunoglobulin G (IgG) preparations that can be given ...
openaire   +1 more source

Home - About - Disclaimer - Privacy